NASDAQ:CBMG
Delisted
Cellular Biomedicine Group Stock News
$19.75
+0 (+0%)
At Close: May 27, 2022
Cellular Biomedicine Group to Report First Quarter 2020 Results on May 6, 2020
08:15pm, Friday, 01'st May 2020
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerativ
Cellular Biomedicine Group (NASDAQ:CBMG) and Novavax (NASDAQ:NVAX) Head-To-Head Contrast
05:14am, Monday, 13'th Apr 2020
Cellular Biomedicine Group (NASDAQ:CBMG) and Novavax (NASDAQ:NVAX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of
's Top Upgrades, Downgrades For March 5, 2020
03:05pm, Thursday, 05'th Mar 2020
Upgrades
For Monolithic Power Systems Inc (NASDAQ: MPWR), Needham upgraded the stock from Hold to Buy. In the fourth quarter, Monolithic Power Systems showed an EPS of...
BTIG Research Downgrades Cellular Biomedicine Gr to Neutral
09:48am, Thursday, 05'th Mar 2020Cellular Biomedicine Group Announces Q4 and Full Year 2019 Financial Results and Recent Operational Progress
09:05pm, Friday, 28'th Feb 2020
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerati
Cellular Biomedicine Group to Report Fourth Quarter and Full Year 2019 Results on February 28, 2020
02:00pm, Wednesday, 26'th Feb 2020
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerati
Cellular Biomedicine Says Received New Prelim. Non-Binding Proposal For $19.50/Share
01:26pm, Monday, 24'th Feb 2020Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee
01:30pm, Monday, 30'th Dec 2019
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG") today announced that the special committee of its board of directors, composed of Alan Au, Edward Schafer, Terry A. Belmont and Wen Tao (Steve)
Cellular Biomedicine Group (CBMG) Presents At 2019 ASH Annual Meeting - Slideshow
12:00am, Wednesday, 11'th Dec 2019China’s Curing Cancer Faster and Cheaper Than Anywhere Else
09:00pm, Tuesday, 10'th Dec 2019
(Bloomberg) -- Zhang Haitao was a basketball-loving teenager who dreamed of going to a specialized sports high school when he got a pain in his right arm that just wouldn’t go away. It turned out to
Cellular Biomedicine Group Presents First Clinical Data of IIT Phase 1 Trial of C-CAR088, a Novel BCMA CAR-T at ASH 2019
01:13pm, Saturday, 07'th Dec 2019
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies, announced earl
